Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic target
Translational Oncology · 2025-04 · 54 · 102330
DOI: 10.1016/j.tranon.2025.102330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2025-04. Verfasst von Yakun Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Affiliated Zhongda Hospi…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Directorate for Geosciences, Suzhou City Science and Technology Bureau.
Abstract (Originalsprache)
BACKGROUND: Breast cancer is one of the most prevalent malignant tumors in women. Mitochondria, essential for cellular function, have altered metabolic activity in cancer cells, influencing tumor regulation and clinical outcomes. The connection between mitochondrial metabolism-related genes and breast cancer prognosis remains underexplored. This study aims to investigate the role of these genes in breast cancer by constructing risk models. METHODS: Breast cancer transcriptome data were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO), and mitochondrial gene data were sourced from the MitoCarta3.01 database. Clustering analysis was conducted using the "ConsensusClusterPlus" package, followed by Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. A prognostic model was built using Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) algorithms. Immune cell infiltration levels were assessed via CIBERSORT and MCPcounter algorithms. Validation of key gene expression was performed on breast cancer tissue specimens and cell models to explore their biological functions in breast cancer cells. RESULTS: The LASSO regression analysis of the TCGA BRCA dataset identified four prognosis-related mitochondrial metabolism genes: MYH11, LTF, FADS2, and PSPHP1. Validation using the GEO dataset confirmed that patients with high-risk scores (based on these four genes) had shorter overall survival compared to those with lower risk scores. Immunological analysis revealed that high-risk patients were less responsive to immunotherapy but more sensitive to conventional chemotherapies. This suggests that combining chemotherapy with immunotherapy might enhance T cell-based treatments. Univariate and multivariate Cox regression confirmed that the mitochondrial gene model was an independent predictor of overall survival, and a nomogram was developed to predict patient prognosis. Tissue validation showed consistent expression patterns with bioinformatic predictions. Functional assays confirmed that FADS2 was highly expressed in breast cancer cells, and its knockout significantly reduced cell invasion, migration, and colony formation. CONCLUSION: This study reveals that mitochondrial metabolism-related genes are closely associated with breast cancer progression, clinical outcomes, and genetic alterations. The findings may offer new avenues for treatment strategies, early intervention, and prognosis prediction in breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.
- Department of Thyroid and Breast Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, China.
- Department of Breast Surgery, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
- Nanjing Medical University, Nanjing 211166, China.
- Department of Breast Surgery, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: Hxie@njmu.edu.cn.
- Department of Breast Surgery, The First Hospital Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: cuiyy@njmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Directorate for Geosciences
- Suzhou City Science and Technology Bureau
- Science and Technology Program of Suzhou
- Beijing Xisike Clinical Oncology Research Foundation
Zitieren
APA
Kang, Y., Meng, Y., Jin, J., Dai, Y., Li, F., Chen, N., Xie, H., & Cui, Y. (2025). Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic target. Translational Oncology, 54, 102330. https://doi.org/10.1016/j.tranon.2025.102330
Vancouver
Kang Y, Meng Y, Jin J, Dai Y, Li F, Chen N, et al. Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic target. Translational Oncology. 2025;54:102330. doi:10.1016/j.tranon.2025.102330
BibTeX
@article{Kang2025,
author = {Kang, Yakun and Meng, You and Jin, Jiangdong and Dai, Yuhan and Li, Fei and Chen, Nuo and Xie, Hui and Cui, Yangyang},
title = {Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic target},
journal = {Translational Oncology},
year = {2025},
volume = {54},
pages = {102330},
doi = {10.1016/j.tranon.2025.102330}
}
EUVIMED